CH642072A5 - Process for the preparation of aminoalkylfuran derivatives - Google Patents

Process for the preparation of aminoalkylfuran derivatives Download PDF

Info

Publication number
CH642072A5
CH642072A5 CH938077A CH938077A CH642072A5 CH 642072 A5 CH642072 A5 CH 642072A5 CH 938077 A CH938077 A CH 938077A CH 938077 A CH938077 A CH 938077A CH 642072 A5 CH642072 A5 CH 642072A5
Authority
CH
Switzerland
Prior art keywords
methyl
hydrogen
formula
group
furanyl
Prior art date
Application number
CH938077A
Other languages
German (de)
English (en)
Inventor
Barry John Price
John Watson Clitherow
John Bradshaw
Original Assignee
Allen & Hanburys Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27448487&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CH642072(A5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB32465/76A external-priority patent/GB1565966A/en
Application filed by Allen & Hanburys Ltd filed Critical Allen & Hanburys Ltd
Priority claimed from KR7701808A external-priority patent/KR810000355B1/ko
Priority to CH1229/84A priority Critical patent/CH651560A5/de
Priority to CH5094/82A priority patent/CH647517A5/de
Priority to CH509382A priority patent/CH640846A5/de
Publication of CH642072A5 publication Critical patent/CH642072A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
    • C07D275/03—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/64—Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
CH938077A 1976-08-04 1977-07-29 Process for the preparation of aminoalkylfuran derivatives CH642072A5 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CH1229/84A CH651560A5 (en) 1977-05-13 1978-01-01 Aminoalkylfuran derivatives, and drugs containing these compounds
CH5094/82A CH647517A5 (en) 1977-07-29 1982-08-27 Amine compounds
CH509382A CH640846A5 (en) 1977-07-29 1982-08-27 Aminoalkylfuran derivative

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB32465/76A GB1565966A (en) 1976-08-04 1976-08-04 Aminoalkyl furan derivatives
GB5068576 1976-12-06
GB2018777 1977-05-13
KR7701808A KR810000355B1 (ko) 1977-05-13 1977-08-04 아미노 알킬푸란 유도체의 제조방법

Publications (1)

Publication Number Publication Date
CH642072A5 true CH642072A5 (en) 1984-03-30

Family

ID=27448487

Family Applications (2)

Application Number Title Priority Date Filing Date
CH938077A CH642072A5 (en) 1976-08-04 1977-07-29 Process for the preparation of aminoalkylfuran derivatives
CH509282A CH641176A5 (en) 1976-08-04 1982-08-27 Process for preparing aminoalkylfuran derivatives

Family Applications After (1)

Application Number Title Priority Date Filing Date
CH509282A CH641176A5 (en) 1976-08-04 1982-08-27 Process for preparing aminoalkylfuran derivatives

Country Status (16)

Country Link
AT (1) AT375931B (xx)
CH (2) CH642072A5 (xx)
CY (1) CY1077A (xx)
DE (2) DE2759959C2 (xx)
DK (2) DK148258C (xx)
ES (2) ES461334A1 (xx)
FI (1) FI72318C (xx)
HK (1) HK55780A (xx)
IE (1) IE45456B1 (xx)
IT (2) IT1126759B (xx)
KE (1) KE3080A (xx)
NZ (2) NZ191383A (xx)
PH (1) PH13540A (xx)
PT (1) PT66874B (xx)
SE (3) SE437373B (xx)
YU (2) YU40006B (xx)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000029400A2 (en) * 1998-11-19 2000-05-25 Dd'zdravlje'- Farmaceutsko-Hemijska Industrija D.D. U. Mešovitoj Svojini Procedure for synthesis of n-[2[[[5- [(dialkilamino) methyl]-2- furanyl] methyl]thyo] ethyl]-n'- alkyl-2-nitro1,1 alkenediamines and their hydrochlorides

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4203909A (en) * 1978-09-26 1980-05-20 Bristol-Myers Company Furan compounds

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000029400A2 (en) * 1998-11-19 2000-05-25 Dd'zdravlje'- Farmaceutsko-Hemijska Industrija D.D. U. Mešovitoj Svojini Procedure for synthesis of n-[2[[[5- [(dialkilamino) methyl]-2- furanyl] methyl]thyo] ethyl]-n'- alkyl-2-nitro1,1 alkenediamines and their hydrochlorides
WO2000029400A3 (en) * 1998-11-19 2000-07-20 Dd Zdravlje Farmaceutsko Hemij Procedure for synthesis of n-[2[[[5- [(dialkilamino) methyl]-2- furanyl] methyl]thyo] ethyl]-n'- alkyl-2-nitro1,1 alkenediamines and their hydrochlorides

Also Published As

Publication number Publication date
HK55780A (en) 1980-10-10
DK337977A (da) 1978-02-05
SE8206556L (sv) 1982-11-17
CY1077A (en) 1980-12-27
IT1126759B (it) 1986-05-21
DK149952C (da) 1987-07-06
DE2759959C2 (xx) 1988-08-04
KE3080A (en) 1980-10-03
DK416384D0 (da) 1984-08-30
IT1221058B (it) 1990-06-21
SE7708521L (sv) 1978-02-05
SE454882B (sv) 1988-06-06
SE8205533L (sv) 1982-09-28
SE437373B (sv) 1985-02-25
IE45456B1 (en) 1982-08-25
IT8548437A0 (it) 1985-08-01
YU40088B (en) 1985-06-30
SE8205533D0 (sv) 1982-09-28
SE454883B (sv) 1988-06-06
PH13540A (en) 1980-06-26
FI772264A (xx) 1978-02-05
DK148258B (da) 1985-05-20
AT375931B (de) 1984-09-25
FI72318B (fi) 1987-01-30
DE2760097C2 (xx) 1989-08-17
FI72318C (fi) 1987-05-11
PT66874B (en) 1979-01-23
ES461334A1 (es) 1979-05-16
YU200082A (en) 1983-01-21
NZ191383A (en) 1980-09-12
DK416384A (da) 1984-08-30
IE45456L (en) 1978-02-04
ES470836A1 (es) 1979-02-16
SE8206556D0 (sv) 1982-11-17
YU191177A (en) 1983-01-21
DK149952B (da) 1986-11-03
YU40006B (en) 1985-06-30
ATA574077A (de) 1984-02-15
PT66874A (en) 1977-09-01
DK148258C (da) 1985-10-14
CH641176A5 (en) 1984-02-15
NZ184759A (en) 1980-09-12

Similar Documents

Publication Publication Date Title
DE2734070C2 (de) Aminoalkylfuranderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2951675C2 (de) Guanidinothiazolverbindungen, Verfahren zu deren Herstellung und Arzneimittelzubereitungen
DE2821409A1 (de) Aminoalkylthiophenverbindungen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
CH643238A5 (en) Aminoalkylbenzene derivatives having a selective action on histamine receptors
JPS5946221B2 (ja) 複素環化合物の製法
DE2461802A1 (de) Pyrazinderivate
DE3216843C2 (de) 3-Thiomethyl-pyridin-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE1593728C3 (de) Substituierte Amidine und Verfahren zu ihrer Herstellung
CH449632A (de) Verfahren zur Herstellung von cyclischen Diazacycloalkanverbindungen
CH642072A5 (en) Process for the preparation of aminoalkylfuran derivatives
AT390952B (de) Verfahren zur herstellung von neuen furan- oder thiophenderivaten
EP1104419B1 (de) N-substituierte azabicycloheptan-derivate, ihre herstellung und verwendung
CH645615A5 (de) 1,1,3,5-substituierte biuretverbindung und pharmazeutische mittel.
EP0110219B1 (de) Heterocyclisch substituierte Nitrile, ihre Herstellung und Verwendung als Arzneimittel
EP0007438A1 (de) Neue substituierte 2-Phenylamino-imidazoline-(2), deren Säureadditionssalze, diese enthaltende Arzneimittel und Verfahren zur Herstellung derselben
CH651560A5 (en) Aminoalkylfuran derivatives, and drugs containing these compounds
DE2655232A1 (de) Aethanolaminderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen
EP0154721A1 (de) Neue Alkanolderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltendes Arzneimittel
CH640846A5 (en) Aminoalkylfuran derivative
DD298100A5 (de) Aminoalkylfuranderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DD210266A5 (de) Verfahren zur herstellung von 3-(ureidocyclohexylamino)-propan-1,2-diolderivaten
AT381937B (de) Verfahren zur herstellung von neuen aminoalkylfuranderivaten sowie deren tautomeren, diastereoisomeren bzw. optischen enantiomeren
KR810000355B1 (ko) 아미노 알킬푸란 유도체의 제조방법
EP0158083A2 (de) Arzneimittel
KR810000356B1 (ko) 아미노 알킬푸란 유도체의 제조방법

Legal Events

Date Code Title Description
PL Patent ceased